About Inavir Pharmatech Private Limited
Data last updated:
Inavir Pharmatech Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the chemical distribution and retail segment of the chemicals and materials sector. It was incorporated on 28 July 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24232TG2011PTC075701. Its GSTIN is 36AACCI6941B1ZT (Telangana). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹1.5 Cr and a paid-up capital of ₹97.39 Lakh. It is led by directors including Vijay Bhaskar Bandla (Managing Director) and Krutika Misra.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Hyderabad, Telangana.
As per the financials filed for FY 2024, the company reported a revenue of ₹5.64 Cr, a growth of 144% compared to the previous year. For the same year it recorded a net profit of ₹2.38 Lakh (net margin 0.4%) and EBITDA of ₹42.52 Lakh (EBITDA margin 7.5%). Revenue has declined at a compounded annual rate (CAGR) of 47% over three years and 29% over five years.
As per MCA filings, the company has open charges of ₹74.87 Lakh and satisfied charges of ₹8.65 Cr on record. Court records list 2 cases involving the company, including 2 filed by the company.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website inavirpharma.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressH.No: 7 – 1 – 643 & 643/1 Bhanu Enclave Flat No.119 Sundar Nagar Besides Esi Hospital S.R N, Agar, Hyderabad, Telangana, India – 500038
- IndustryChemicals and Materials, Chemical Distribution & Retail
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Inavir Pharmatech Private Limited
The main business activity of Inavir Pharmatech is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Inavir Pharmatech Private Limited FY 2025 filings available
Inavir Pharmatech Private Limited reported revenue of ₹5.64 Cr (up 144% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Inavir Pharmatech Private Limited
Revenue rose 144% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 29%. EBITDA rose 2% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Inavir Pharmatech Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹42.52 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹2.38 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Inavir Pharmatech Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 7.5% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.4% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Inavir Pharmatech are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Inavir Pharmatech Private Limited
Inavir Pharmatech Private Limited is compared with the companies closest to it by revenue in the Chemicals industry (Chemical Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Chems Deal Inc Private Limited | ₹5.66 Cr (FY 2025) | •••• | •••• | 81.0% | •••• | Indore, Madhya Pradesh, India |
| Lema Chemicals Private Limited | ₹5.66 Cr (FY 2025) | •••• | •••• | 62.0% | •••• | Ratnagiri, Maharashtra, India |
| Kashi Realtors Private Limited | ₹5.66 Cr (FY 2022) | •••• | •••• | -5.0% | •••• | Lucknow, Uttar Pradesh, India |
| Aci Clean Energy Private Limited | ₹5.66 Cr (FY 2025) | •••• | •••• | 8.0% | •••• | Mumbai, Maharashtra, India |
| Amro Manufacturers Private Limited | ₹5.65 Cr (FY 2025) | •••• | •••• | 3.0% | •••• | Mumbai, Maharashtra, India |
| Inavir Pharmatech Private Limited this company | ₹5.64 Cr (FY 2024) | •••• | •••• | 144.0% | •••• | Hyderabad, Telangana, India |
| Purusita Industries Private Limited | ₹5.64 Cr (FY 2025) | •••• | •••• | -24.0% | •••• | Noida, Uttar Pradesh, India |
| JKV Chemicals Private Limited | ₹5.64 Cr (FY 2025) | •••• | •••• | 16.0% | •••• | Tiruppur, Tamil Nadu, India |
| Vaman Healthcare and Exports Private Limited | ₹5.63 Cr (FY 2024) | •••• | •••• | 27.0% | •••• | Chennai, Tamil Nadu, India |
| Tinctura Colour Private Limited | ₹5.62 Cr (FY 2022) | •••• | •••• | -81.0% | •••• | Ahmedabad, Gujarat, India |
| Ishita Fashions Private Limited | ₹5.62 Cr (FY 2025) | •••• | •••• | 20.0% | •••• | New Delhi, Delhi, India |
Peers are the five companies nearest above and the five nearest below Inavir Pharmatech by revenue in the Chemicals industry (Chemical Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Inavir Pharmatech Private Limited
Inavir Pharmatech Private Limited is audited by C S P K AND ASSOCIATES for the financial year 2022.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| C S P K AND ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Inavir Pharmatech Private Limited
Inavir Pharmatech has 3 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sujatha Tanniru | Additional Director | 22 Jul 2015 | 11 Years 2 Months | Current |
| Vijay Bhaskar Bandla Also directs: Hakue Labs Private Limited, Iona Pharmatech Private Limited | Managing Director | 28 Jul 2011 | 15 Years 2 Months | Current |
| Krutika Misra Also directs: Iona Pharmatech Private Limited | Director | 30 Sep 2014 | 12 Years 0 Months | Current |
Ownership and Shareholding of Inavir Pharmatech Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Inavir Pharmatech Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 19 Apr 2022 | Others | ₹74.87 Lakh | Open |
| 20 Jul 2019 | Others | ₹8.15 Cr | Satisfied |
| 29 Mar 2016 | Others | ₹50 Lakh | Satisfied |
Total charge records: 3 View all charges
Legal Cases of Inavir Pharmatech Private Limited
Inavir Pharmatech Private Limited has 2 court cases on record: 2 filed by Inavir Pharmatech. All cases are disposed. Status as checked between 02 Oct 2026 and 03 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 1 | 0 | 0 |
| District courts | 1 | 0 | 0 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Hyderabad CCC, Telangana | Criminal complaint | Filed by the company against A-1 M/S. Qualitech Pharma | Disposed |
| High Court for State of Telangana | Writ petition | Filed by the company against State of Telangana | Disposed |
Full case history
All 2 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Inavir Pharmatech Private Limited
Employment history and EPFO contributions of people linked to Inavir Pharmatech.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
CIN History of Inavir Pharmatech Private Limited
Inavir Pharmatech has one previous CIN (Corporate Identification Number): U24232AP2011PTC075701. The current CIN is U24232TG2011PTC075701, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24232TG2011PTC075701 | Current |
| U24232AP2011PTC075701 | Previous |
Recent Activity on Inavir Pharmatech Private Limited
Inavir Pharmatech Private Limited has 10 board changes on record since 2011: 4 appointments and 6 cessations. The latest: Abdul Mukaram Mohammed was appointed as Director on 30 Dec 2023.
7 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Inavir Pharmatech Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Inavir Pharmatech Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Inavir Pharmatech Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Inavir Pharmatech Private Limited
Inavir Pharmatech has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AACCI6941B1ZT | Telangana | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Inavir Pharmatech Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Inavir Pharmatech Private Limited
Inavir Pharmatech is an active private limited company based in Hyderabad, Telangana, India. The company works in chemical distribution and retail, within the chemicals and materials industry. It was incorporated on 28 July 2011 (15+ years old) and is registered under CIN U24232TG2011PTC075701.
Inavir Pharmatech reported revenue of ₹5.64 Cr for FY 2024 (up 144% YoY).
Inavir Pharmatech has 3 current directors:
- Vijay Bhaskar Bandla - Managing Director
- Sujatha Tanniru - Additional Director
- Krutika Misra - Director
Inavir Pharmatech reported a net profit of ₹2.38 Lakh (net margin 0.4%) and EBITDA of ₹42.52 Lakh (EBITDA margin 7.5%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Inavir Pharmatech is -47% over three years and -29% over five years. In the latest year (FY 2024) revenue rose 144%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Inavir Pharmatech is 36AACCI6941B1ZT, registered in Telangana. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Inavir Pharmatech is U24232TG2011PTC075701. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Inavir Pharmatech has 2 court cases on record: 2 filed by the company. Most are in the high courts.
Inavir Pharmatech was incorporated on 28 July 2011, making it 15+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Inavir Pharmatech by revenue are Chems Deal Inc Private Limited, Lema Chemicals Private Limited, Kashi Realtors Private Limited, Aci Clean Energy Private Limited, Amro Manufacturers Private Limited and 5 more, all in the Chemicals industry (Chemical Retail and Distribution).
Abdul Mukaram Mohammed was appointed as Director on 30 Dec 2023. Jagadeshwar Rao Madhavaram ceased to be Director on 08 Oct 2015. Sujatha Tanniru was appointed as Additional Director on 22 Jul 2015. Inavir Pharmatech has 10 board changes on record in total.